IL1B and Alzheimer disease: Furthermore, luteolin treatment inhibited neuroinflammation (IL‐1β, IL‐6, TNF‐α, NO, COX‐2, and iNOS proteins), astrocyte hyperactivation as well as improved spatial learning and reduced memory deficits in triple‐transgenic mouse model of AD (Kou et al. 2021).